Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: Role of mast cell protease-5

British Journal of Pharmacology

Volumn 145, Issue 1, 2005, Pages 24-33

  Russo, Annapina ^a   Russo, Giulia ^a   Peticca, Manuela ^a   Pietropaolo, Concetta ^a   Di Rosa, Massimo ^a   Iuvone, Teresa ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; Chronic inflammation; Chymases; Granuloma formation; Ketotifen; Mast cells; rMCP 5

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARRAGEENAN; CHYMASE; CHYMOSTATIN; COMPOUND 48-80; HEMOGLOBIN; KETOTIFEN; MAST CELL PROTEASE 5; MESSENGER RNA; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; GENE EXPRESSION; GRANULOMA; HEMOGLOBIN DETERMINATION; MALE; MAST CELL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL DEGRANULATION; GENE EXPRESSION; GRANULOMA; KETOTIFEN; MALE; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES;

EID: 18744391085     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706112     Document Type: Article

References (47)

1. BREIER, G., ALBRECHT, U., STERRER, S. & RISAU, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development, 114, 524-532.
2. BROWN, J.F., CHAFEE, K.A. & TEPPERMAN, B.L. (1998). Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon. Br. J. Pharmacol., 123, 31-38.
3. CHANDRASEKHARAN, U.M., SANKER, S., GLYNIAS, M.Y., KARNIK, S.S. & HUSAIN, A. (1996). Angiotensin II-forming activity in a reconstructed ancestral chymase. Science, 271, 502-505.
4. COLVILLE-NASH, P.R., ALAM, C.A.S., APPLETON, I., BROWN, J.R., SEED, M. & WILLOUGHBY, D.A. (1995). The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J. Pharmacol. Exp. Ther., 274, 1463-1471.
5. COLVILLE-NASH, P.R & SCOTT, D.L. (1992). Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann. Reheum. Dis., 51, 919-925.
6. CROOKE, S.T. (1993). Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J., 7, 533-539.
7. CRUM, R., SZABO, S. & FOLKMAN, J. (1985). A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science, 230, 1375-1378.
8. DI ROSA, M., GIROUD, J.P. & WILLOUGHBY, D.A. (1971). Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol., 104, 15-29.
9. ESPOSITO, G., LIGRESTI, A., IZZO, A.A., BISOGNO, T., RUVO, M., DI ROSA, M., DI MARZO, V. &: IUVONE, T. (2002). The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J. Biol. Chem., 277, 50348-50354.
10. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1, 27-31.
11. FUKAMI, H., OHUNISHI, H. & MIYAZAKI, M. (1998). Chymase: its pathophysiological roles and inhibitors. Curr. Pharm Des., 4, 439-453.
12. GALLI, S.J. (2000). Mast cells and basophils. Curr. Opin. Hematol., 7, 32-39.
13. GALLI, S.J., WEDEMEYER, J. & TSAI, M. (2002). Analyzing the roles of mast cells and basophils in host defense and other biological responses. Int. J. Hematol, 75, 363-369.
14. GILLES, S., ZAHLER, S., WELSCH, U., SOMMERHOFF, C.P. & BECKER, B.F. (2003). Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc. Res., 60, 608-616.
15. GORDON, J.R. & GALLI, S.J. (1990). Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature, 346, 274-276.
16. GRANT, S.M., GOA, K.L., FITTON, A. & SORKIN, E.M. (1990). Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drug, 40, 412-448.
17. GRUTZKAU, A., KRUGER-KRASAGAKES, S., BAUMEISTER, H., SCHWARTZ, C., KOGEL, H., WELKER, P., LIPPERT, U., HENZ, B.M. & MOLLER, A. (1998). Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell, 9, 875-884.
18. HE, S. & WALLS, A.F. (1998). The induction of a prolonged increase in microvascular permeability by human mast cell chymase Eur. J. Pharmacol., 352, 91-98.
19. HORI, Y., HU, D.E., YASUI, K., SMITHER, R.L., GRESHAM, G.A. & FAN, T.P. (1996). Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br. J. Pharmacol., 118, 1584-1591.
20. IDE, H., ITOH, H., TOMITA, M., MURAKUMO, Y., KOBAYASHI, H., MARUYAMA, H., OSADA, Y. & NAWA, Y. (1995). Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases. Biochem. J., 311, 675-680.
21. IRANI, A.A., SCHECHTER, N.M., CRAIG, S.S., DE BLOIS, G. & SCHWARTZ, L.B. (1986). Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. U.S.A., 83, 4464-4468.
22. IUVONE, T., CARNUCCIO, R. & DI ROSA, M. (1994). Modulation of granuloma formation by endogenous nitric oxide. Eur. J. Pharmacol., 265, 89-92.
23. IUVONE, T., VAN DEN BOSSCHE, R., D'ACQUISTO, F., CARNUCCIO, R. & HERMAN, A.G. (1999). Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br. J. Pharmacol., 128, 700-704.
24. JACKSON, J.R., SEED, M.P., KIRCHER, C.H., WILLOUGHBY, D.A. & WINKLER, J.D. (1997). The codependence of angiogenesis and chronic inflammation. FASEB J., 11, 457-465.
25. JOHNSTON, B., BURNS, A.R. & KUBES, P. (1998). A role for mast cells in the development of adjuvant-induced vasculitis and arthritis. Am. J. Pathol., 152, 555-613.
26. KARLSON, U., PEJLER, G., FRÖMAN, G. & HELLMAN, L. (2002). Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. J. Biol. Chem., 277, 18579-18585.
27. KATADA, J., MURAMATSU, M., HAYASHI, I., TSQTSUMI, M., KONISHI, Y. & MAJIMA, M. (2002). Significance of vascular endothelial cell growth factor upregulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J. Pharmacol. Exp. Ther., 302, 949-956.
28. LEAL-BERUMEN, I., CONLON, P. & MARSHALL, J.S (1994). IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol., 152, 5468-5476.
29. LEES, M., TAYLOR, D.J. & WOOLLEY, D.E. (1994). Mast cells proteinases activate precursor forms of collagenase and stromelysin, but not gelatinase A and B. Eur. J. Biochem., 223, 171-177.
30. LUTZELSCHWAB, C, PEJLER, G., AVESKOGH, M. & HELLMAN, L. (1997). Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J. Exp. Med., 185, 13-29.
31. MARTIN, U. & BAGGIOLINI, M. (1981). Dissociation between the anti-anaphylactic and the anti-histaminic actions of ketotifen Naunyn-Schmied. Arch. Pharmacol., 316, 186-189.
32. MARTIN, U. & ROMER, D. (1978). The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene. Arzneim. Forsch./Drug Res., 28, 770-782.
33. MEININGER, C.J. & ZETTER, B.R. (1995). Mast cells and angiogenesis. Sem. Cancer Biol., 3, 73-79.
34. MICAN, J.M. & METCALFE, D.D. (1990). Arthritis and mast cell activation. J. Allergy Clin. Immunol., 86, 677-683.
35. MURAMATSU, M., KATADA, J., HATTORI, M., HAYASHI, I. & MAJIMA, M. (2000a). Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol., 402, 181-191.
36. MURAMATSU, M., KATADA, J., HAYASHI, I. & MAJIMA, M. (2000b). Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin- dependent pathway in the hamster sponge angiogenesis model. J. Biol. Chem., 275, 5545-5552.
37. MURAMATSU, M., YAMADA, M., TAKAI, S. & MIYAZAKI, M. (2003). Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas. Br. J. Pharmacol., 137, 554-560.
38. RAKUSAN, K., SARKAR, K., TUREK, Z. & WICKER, P. (1990). Mast cells in the rat heart during normal growth and in cardiac hypertrophy. Circ. Res., 66, 511-516.
39. REILLY, C.F., TEWKSBURY, D.A., SCHECHTER, N.M. & TRAVIS, J. (1982). Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem., 257, 8619-8622.
40. RHODIN, J.A.G. & FUJITA, H. (1989). Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analyses. J. Submicrosc. Cytol. Pathol., 21, 1-34.
41. RIBATTI, D., VACCA, A., NICO, B., CRIVELLATO, E., RONCALI, L. & DAMMACCO, F. (2001). The role of mast cells in tumour angiogenesis. Br. J. Haematol., 115, 1-9 (Review).
42. RISAU, W. (1997). Mechanisms of angiogenesis. Nature, 386, 671-674.
43. SOLIVAN, S., SELWOOD, T., WANG, Z.M. & SCHECHTER, N.M. (2002). Evidence for diversity of substrate specificity among members of the chymase family of serine proteases. FEBS Lett., 512, 133-138.
44. SORBO, J., JAKOBSSON, A. & NORRBY, K. (1994). Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int. J. Exp. Pathol., 75, 43-50.
45. STEIN, C.A. (1995). Does antisense exist? Nature Med., 1, 1119-1121.
46. SUEISHI, K., YONEMITSU, Y., NAKAGAWA, K., KANEDA, Y., KUMAMOTO, M. & NAKASHIMA, Y. (1997). Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor. Ann. N. Y. Acad. Sci., 811, 311-322.
47. WAGNER, R.W. (1995). The state of the art in antisense research. Nat. Med., 1, 1116-1118.